Benign Migratory Glossitis and Hand–Foot Syndrome Co-occurrence in a Renal Cell Carcinoma Patient on Sorafenib

Sorafenib, a multitargeted tyrosine kinase inhibitor, is used for advanced renal cell carcinoma but can cause various cutaneous side effects. We report the case of a 50-year-old male with metastatic renal cell carcinoma who developed both benign migratory glossitis (BMG) and hand–foot syndrome (HFS)...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ramamoorthy Logamoorthy, Ragul Raj Elango, Shruti Ganesh, Suganya Radhakrishnan, Kaliaperumal Karthikeyan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2025-04-01
coleção:	Clinical Dermatology Review
Assuntos:	benign migratory glossitis hand–foot syndrome sorafenib
Acesso em linha:	https://journals.lww.com/10.4103/cdr.cdr_142_24
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!